Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group Turn Therapeutics, Inc. a clinical-stage dermatology company developing novel therapies for inflammatory skin diseases, today announced it has entered into a growth capital loan facility with Avenue…
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ® The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME…
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a…
Meiji Seika Pharma Co., Ltd. has announced the initiation of a Phase I clinical trial for ME3241, an innovative anti-PD-1 agonist monoclonal antibody developed through a research collaboration with the Foundation for Biomedical Research and Innovation at Kobe (FBRI). The…
Alvaro Grande Joins Burckhardt Compression as New Head of Services Burckhardt Compression has announced the appointment of Alvaro Grande as its new Head of Services, bringing over two decades of extensive experience in the compression industry. With a career spanning…
KCAS Bio’s Lyon Site Renews GLP Compliance, Strengthening Support for IND-Enabling Studies KCAS Bio has announced that its European bioanalytical facility in Lyon has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP). The renewal was granted in…
Veristat Expands Regulatory and Clinical Trial Support for Chinese Pharmaceutical and Medical Device Companies Entering Global Markets Veristat, a global contract research organization (CRO) and consulting firm known for its expertise in complex clinical trials, has announced the expansion of…
ExxonMobil Board Recommends Moving Legal Domicile from New Jersey to Texas ExxonMobil announced that its Board of Directors has unanimously recommended that shareholders approve a proposal to change the company’s legal domicile from New Jersey to Texas. The move, known…
Modular Genetics partners with the New American Industrial Alliance to accelerate advanced biomanufacturing and strengthen U.S. techno-industrial leadership. Modular Genetics, Inc., a pioneering company in the field of Industrial Biotechnology, has announced that it has officially joined the New American…
MindWalk Introduces B Cell Llama™ to Accelerate Nanobody Discovery for Next-Generation Therapies MindWalk Holdings Corp a bio-native artificial intelligence company focused on advanced drug discovery, has announced the launch of B Cell Llama™, a specialized platform designed to discover VHH…
Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…
Missouri Court Grants Preliminary Approval for Roundup™ Class Settlement to Address Current and Future Claims A judge in the Circuit Court of the City of St. Louis, Missouri has granted preliminary approval for a proposed class action settlement aimed at…